Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05394831
Title A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors J Ints Bio
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Chao Family Comprehensive Cancer Center, University of California Irvine Healthcare NOT_YET_RECRUITING Orange California 92868 United States Details
Chungbuk National University Hospital RECRUITING Cheongju-si Chungcheongbuk-do 28644 Korea, Republic of Details
National Cancer Center RECRUITING Goyang-si Gyeonggi-do 03722 Korea, Republic of Details
Seoul National University Hospital NOT_YET_RECRUITING Seoul 03080 Korea, Republic of Details
Asan Medical Center RECRUITING Seoul 05505 Korea, Republic of Details
Samsung Medical Center NOT_YET_RECRUITING Seoul 06351 Korea, Republic of Details
The Catholic University, St. Mary's Hospital NOT_YET_RECRUITING Seoul 06591 Korea, Republic of Details
Yonsei University Health System, Severance Hospital RECRUITING Seoul 10400 Korea, Republic of Details
The Catholic University, St. Vincent's Hospital NOT_YET_RECRUITING Suwon-si 16247 Korea, Republic of Details
Faculty of Medicine Ramathibodi Hospital, Mahidol University NOT_YET_RECRUITING Ratchathewi Bangkok 10400 Thailand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field